Tong Yang Life Insurance Company Limited operates in the Life insurance sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tong Yang Life Insurance Company Limited with three other
insurance companies in Asia:
Hubei Biocause Pharmaceutical Co., Ltd.
sales of 30.47 billion Chinese Renmimbi [US$4.34 billion]
of which 117%
Bajaj Finserv Limited
(305.99 billion Indian Rupees [US$4.24 billion]
of which 56%
was Insurance), and
Orange Life Insurance Ltd
(5.02 trillion Korean Won [US$4.29 billion]
of which 100%
was Insurance & Related Activities).
Tong Yang Life Insurance Company Limited reported sales of 5.00 trillion Korean Won (US$4.27 billion)
December of 2018.
decrease of 25.8%
versus 2017, when the company's sales were 6.74 trillion Korean Won.